Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of X4 Pharmaceuticals Inc (NASDAQ: XFOR) was $0.76 for the day, up 7.09% from the previous closing price of $0.71. In other words, the price has increased by $7.09 from its previous closing price. On the day, 2.59 million shares were traded. XFOR stock price reached its highest trading level at $0.7979 during the session, while it also had its lowest trading level at $0.7173.
Ratios:
Our analysis of XFOR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.71 and its Current Ratio is at 3.71. In the meantime, Its Debt-to-Equity ratio is 56.03 whereas as Long-Term Debt/Eq ratio is at 54.94.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 12, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $3 previously.
On December 22, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on December 22, 2022, with a $3 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 11 ’24 when Mostafa Adam S. sold 52,500 shares for $0.88 per share. The transaction valued at 46,347 led to the insider holds 0 shares of the business.
Ragan Paula sold 49,678 shares of XFOR for $43,856 on Mar 11 ’24. The President and CEO now owns 765,068 shares after completing the transaction at $0.88 per share. On Mar 11 ’24, another insider, DiBiase Mary, who serves as the Chief Operating Officer of the company, sold 15,409 shares for $0.88 each. As a result, the insider received 13,591 and left with 291,752 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XFOR now has a Market Capitalization of 127515320 and an Enterprise Value of 104921160.
Stock Price History:
The Beta on a monthly basis for XFOR is 0.38, which has changed by -0.58296704 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, XFOR has reached a high of $1.95, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is -16.79%, while the 200-Day Moving Average is calculated to be -18.22%.
Shares Statistics:
XFOR traded an average of 3.10M shares per day over the past three months and 2726390 shares per day over the past ten days. A total of 167.43M shares are outstanding, with a floating share count of 117.37M. Insiders hold about 30.11% of the company’s shares, while institutions hold 39.62% stake in the company. Shares short for XFOR as of 1719532800 were 13882654 with a Short Ratio of 4.48, compared to 1717113600 on 11877895. Therefore, it implies a Short% of Shares Outstanding of 13882654 and a Short% of Float of 8.34.
